[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Ear Care in Algeria

April 2013 | 19 pages | ID: ED2ACC09DAEEN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Ear care registered a healthy 6% value growth in 2012 and remained dominated by a few top brands, such as Cerulyse and Otipax. Most common symptoms for OTC ear care concern wax removal and otitis, for other cases, consumers prefer a doctor’s visit which resulted in ear care generating one of the smallest consumer health value sales.

Euromonitor International's Ear Care in Algeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Ear Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Ear Care: Value 2007-2012
  Table 2 Sales of Ear Care: % Value Growth 2007-2012
  Table 3 Ear Care Company Shares 2008-2012
  Table 4 Ear Care Brand Shares 2009-2012
  Table 5 Forecast Sales of Ear Care: Value 2012-2017
  Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Saidal Algerie SpA in Consumer Health (algeria)
Strategic Direction
Key Facts
Summary 1 Saidal Algerie SpA: Key Facts
Summary 2 Saidal Algerie spa: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Saidal Algerie spa: Competitive Position 2012
Executive Summary
Consumer Health Maintains Solid Market Performance in 2012
Self-medication Resists Despite the Introduction of An Easier Refund System for Prescription Drugs
International Brands Continue To Lead Consumer Health Environment
Chemists/pharmacies Remains the Major Distribution Channel
Value Performance Expected To Slow Down for Consumer Health Categories
Key Trends and Developments
Domestic Production Increasing But Focus Is on Prescription Drugs
Demand for Phytotherapy and Vitamins and Dietary Supplements Continues To See Dynamic Growth
Self-medication Remains Dominant Despite Improved Social Security Refunds
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 4 OTC Healthcare Switches 2010-2012
Sources
Summary 5 Research Sources


More Publications